Discounted Cash Flow (DCF) Analysis Levered
Biophytis S.A. (ALBPS.PA)
0.0213 €
-0.00 (-4.91%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Projected | 2018 Projected | 2019 Projected | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | - | - | - | - | - | - | - | - | - | - |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Weighted Average Cost Of Capital
Share price | $ 0.0,213 |
---|---|
Beta | 1.116 |
Diluted Shares Outstanding | 118.28 |
Cost of Debt | |
Tax Rate | 0.00 |
After-tax Cost of Debt | 28.82% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.958 |
Total Debt | 15.38 |
Total Equity | 2.52 |
Total Capital | 17.90 |
Debt Weighting | 85.92 |
Equity Weighting | 14.08 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Projected | 2018 Projected | 2019 Projected | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | - | - | - | - | - | - | - | - | - | - |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
WACC | ||||||||||
PV LFCF | - | - | - | - | - | - | - | - | - | - |
SUM PV LFCF | - |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 26.02 |
Free cash flow (t + 1) | - |
Terminal Value | - |
Present Value of Terminal Value | - |
Intrinsic Value
Enterprise Value | - |
---|---|
Net Debt | -8.55 |
Equity Value | - |
Shares Outstanding | 118.28 |
Equity Value Per Share | - |